Catamaran Corporation Reduces Overall Drug Trend to 2.6 Percent in 2012

   Catamaran Corporation Reduces Overall Drug Trend to 2.6 Percent in 2012

PR Newswire

LISLE, IL, June 12, 2013

Record-setting generic dispensing rate, clinical strategy reduced drug trend
for members and clients year-over-year

LISLE, IL, June 12, 2013 /PRNewswire/ - Catamaran Corp. (NASDAQ: CTRX) (TSX:
CCT), a leading provider of pharmacy benefit management (PBM) services and
technology, recently released its 2012 Informed Trends™ report, revealing a
0.9 percentage point year-over-year reduction in overall drug trend from 3.5
percent (2011) to 2.6 percent (2012). Catamaran's record-setting generic
dispensing rate of 81.9 percent - a 5 percentage point increase over 2011 -
contributed to a 1.2 percent decrease in traditional drug spend.

The report, Healthcare HD - The Power of High Definition, also found that
highly managed clients - those that utilize Catamaran's full scope of
clinical, communications and channel-management programs - experienced a 1
percent drug trend compared to 2.6 percent for the commercial
book-of-business.

"The availability of new generic medications coupled with Catamaran's
customized programs and personalized interventions generated cost savings for
clients across all segments," said Mark Thierer, Chairman and CEO of
Catamaran. "While we are always focused on maximizing value for clients' and
members' healthcare dollars, Catamaran is moving beyond price of medications,
channel and distribution to focus on the power of data and insights to improve
the quality of care, creating healthier communities across the nation."

Specialty medications accounted for approximately 20 percent of the overall
U.S. drug market by volume in 2012. To manage this high-cost market segment
expected to increase to 23 percent of total global volume by 2018, Catamaran
launched its specialty brand BriovaRx™ last year, delivering savings to
clients and hands-on, individualized care to patients.

"An increase in chronic and complex diseases points to the need to encourage
preventive health measures," said Sumit Dutta, Senior Vice President and Chief
Medical Officer at Catamaran. "Catamaran's personalized approach engages
at-risk members at the right time with the right intervention driving better
healthcare decisions and financial outcomes."

Healthcare HD - The Power of High Definition, the theme of the report,
highlights Catamaran's clinical approach of driving national strategies,
shaped for local differences and personalized for individual patients.
National best practices combined with Catamaran's expertise in technology and
analytics form the foundation for Catamaran's clinical programs. Regional
presence, local partnerships and flexible technology create connections in the
communities Catamaran serves and enable it to customize programs to meet
specific client needs. Individual risk scores and tailored messaging and
interventions engage members to take charge of their health. Catamaran
employs all three levels as a proven model to lower pharmacy trend and produce
the best outcomes.

The full report: Informed Trends: Healthcare HD  is available for download.
Additionally, new for this year, Catamaran released its 2012 drug trend
information through an infographic portal that allows visitors to engage with
the content in visual ways.

About Catamaran

Catamaran, the industry's fastest-growing pharmacy benefits manager, helps
organizations and the communities they serve take control of prescription drug
costs. Managing more than 250 million prescriptions each year on behalf of 25
million members, our flexible, holistic solutions improve patient care and
empower individuals to take charge of their health. Processing one in every
five prescription claims in the U.S., Catamaran's skill and scale deliver
compelling financial results and sustainable improvement in the overall health
of members. Catamaran is headquartered in Lisle, Ill. with multiple locations
in the U.S. and Canada. For more information, please visit CatamaranRx.com,
and for industry news and information follow Catamaran on Twitter,
@CatamaranCorp. 

SOURCE Catamaran

Contact:

Tony Perkins
Investor Relations
Catamaran
Tel: (312) 261-7805
tony.perkins@catamaranRx.com
 
Press spacebar to pause and continue. Press esc to stop.